Chinese biological 14 central nervous system infection pathogen nucleic acid detection kit approved for market.

On August 25th, the "Fourteen Central Nervous System Infectious Pathogen Nucleic Acid Detection Kit" developed by China Biotech Shanghai Jienor Biotechnology Co., Ltd. was officially approved for market launch. This is the first registration certificate for class III medical devices used for the auxiliary diagnosis of central nervous system infections approved by the National Medical Products Administration for a domestic company.